Skip to Main Content


* (OBGYN Education & Research Profile)

Charles Lockwood, MD

Charles Lockwood, MD

Executive Vice President, USF Health

Vice President Health / Dean Co, USF Health VP Office

Dean, USF Health Morsani College of Medicine


Professor, Health Policy and Management, USF College of Public Health

Contact Info

  • 12901 Bruce B. Downs Blvd.
    Tampa FL 33612
  • Academic Email:
  • Academic Phone: 8139740533
  • View My C.V.


  • MS, Health Care Management, Harvard School of Public Health, 2009
  • MD, Medicine, University of Pennsylvania School of Medicine, 1981

Interdisciplinary and Emerging Signature Programs

  • Women & Children's Health

Research Interests

  • Pathogenesis of, and biomarkers for, preterm birth and preeclampsia; Regulation of decidual progesterone receptor expression; Regulation of endometrial hemostasis and angiogenesis; Decidual natural killer (NK) cell biology; and Health care finance and delivery models


  • Lifetime Achievement Award (Society for Maternal Fetal Medicine - 2017)
  • Fellow (American Association for Advancement of Science - 2016)
  • Beacon Award (NICHD Frontiers in Reproduction - 2015)
  • President's Distinguished Scientist Award (Society for Reproductive Investigation - 2013)
  • Member (National Academy of Medicine (Formerly National Institute of Medicine) - 2010)


  • Fellow (The American Congress of Obstetricians and Gynecologists, 2018 - Present)
  • Member (Society for Maternal-Fetal Medicine, 2018 - Present)
  • Fellow (American Institute for Ultrasound in Medicine, 2018 - Present)
  • President (American Gynecological and Obstetrical Society, 2017 - Present)

Recent Publications

  • Rachel G, Sinkey Jasmin Lacevic Tea Reljic Iztok Hozo Kelly S, Gibson Anthony O, Odibo Benjamin Djulbegovic Charles J, Lockwood. Elective induction of labor at 39 weeks among nulliparous women: The impact on maternal and neonatal risk PLOS ONE. , 2018.
  • Casale TB, Teng MN, Morano JP, Unnasch T, Lockwood CJ. Zika virus: An emerging infectious disease with serious perinatal and neurologic complications. The Journal of allergy and clinical immunology. 141(2) : 482-490, 2018.
  • Arlier S, Murk W, Guzeloglu-Kayisli O, Semerci N, Larsen K, Tabak MS, Arici A, Schatz F, Lockwood CJ, Kayisli UA. The extracellular signal-regulated kinase 1/2 triggers angiogenesis in human ectopic endometrial implants by inducing angioblast differentiation and proliferation. American journal of reproductive immunology (New York, N.Y. : 1989). 78(6) , 2017.
  • Kumar D, Moore RM, Mercer BM, Mansour JM, Mesiano S, Schatz F, Lockwood CJ, Moore JJ. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening. American journal of obstetrics and gynecology. 217(6) : 695.e1-695.e14, 2017.
  • Shapiro JP, Guzeloglu-Kayisli O, Kayisli UA, Semerci N, Huang SJ, Arlier S, Larsen K, Fadda P, Schatz F, Lockwood CJ. Thrombin impairs human endometrial endothelial angiogenesis; implications for progestin-only contraceptive-induced abnormal uterine bleeding. Contraception. 95(6) : 592-601, 2017.
  • Guzel E Arlier S Guzeloglu-Kayisli O Tabak MS Ekiz T Semerci N Larsen K Schatz F Lockwood CJ Kayisli UA. Endoplasmic reticulum stress and homeostasis in reproductive physiology and pathology. Int J Mol Sci. 18(4) , 2017.
  • Hu Z, Cheng J, Xu J, Ruf W, Lockwood CJ. Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy. Angiogenesis. 20(1) : 85-96, 2017.
  • Schatz F Guzeloglu-Kayisli O Arlier S Kzayisli UA Lockwood CJ, . The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding Hum Reprod Update. 22(4) : 497-515, 2016.
  • Mhatre MV Potter JA Lockwood CJ Krikun G Abrahams VM. Thrombin augments LPS-induced human endometrial endothelial cell inflammation via PAR1 activation. Am J Reprod Immunol. , 2016.
  • Chedraui P Solis EJ Perez-Lopez FR Schatz F Kayisli U Escobar GS Loja-Chango R Hidalgo L Lockwood CJ, . Umbilical cord plasma interferon-induced protein 10 (IP-10) and interferon-induced T cell alpha chemoattractant (ITAC) levels are lower in women with severe preeclampsia J Perinat Med. 44(3) : 291-294, 2016.